| Limitations of heartburn and other societies’ criteria in Barrett’s screening for detecting de novo esophageal adenocarcinoma T Sawas, SA Zamani, S Killcoyne, A Dullea, KK Wang, PG Iyer, ... Clinical Gastroenterology and Hepatology 20 (8), 1709-1718, 2022 | 26 | 2022 |
| IUCN conservation status does not predict glucocorticoid concentrations in reptiles and birds LB Martin, M Vitousek, JW Donald, T Flock, MJ Fuxjager, W Goymann, ... Integrative and comparative biology 58 (4), 800-813, 2018 | 18 | 2018 |
| A mixed-methods assessment of a peer-enforced tobacco-and smoke-free policy at a large urban university A Gatto, SE Powell, EF Walters, S Zamani, LB Sales, R DeBate Journal of community health 44, 365-376, 2019 | 17 | 2019 |
| Dietary polyunsaturated fat intake in relation to head and neck, esophageal, and gastric cancer incidence in the National Institutes of Health–AARP Diet and Health Study SA Zamani, KM McClain, BI Graubard, LM Liao, CC Abnet, MB Cook, ... American Journal of Epidemiology 189 (10), 1096-1113, 2020 | 13 | 2020 |
| Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families JCA Lacson, SA Zamani, LAR Froes, N Mitra, L Qian, SH Doyle, E Azizi, ... BMC Public Health 21, 1-16, 2021 | 8 | 2021 |
| Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma S Abbas, O Pich, G Devonshire, SA Zamani, A Katz-Summercorn, ... Nature Communications 14 (1), 4239, 2023 | 6 | 2023 |
| 96 UTILITY OF A MULTI-GENE METHYLATION PANEL TO RISK-STRATIFY PATIENTS WITH BARRETT'S ESOPHAGUS AFTER RADIOFREQUENCY ABLATION WK Tan, S Massia, DR Hayward, GM Villarejo, S Warburton, I Modolell, ... Gastroenterology 166 (5), S-24-S-25, 2024 | | 2024 |
| 861 MODELLING FROM A MULTICENTRE, PRAGMATIC, RANDOMISED CONTROLLED TRIAL IDENTIFIES THE TARGET SCREENING POPULATION AND EXPECTED YIELD FOR BARRETT'S ESOPHAGUS AND ESOPHAGEAL … WK Tan, R Maroni, J Offman, S Zamani, M Di Pietro, M O'Donovan, ... Gastroenterology, 2024 | | 2024 |
| Disentangling oncogenic amplicons in esophageal adenocarcinoma AWT Ng, DP McClurg, B Wesley, SA Zamani, E Black, A Miremadi, ... nature communications 15 (1), 4074, 2024 | | 2024 |
| Targeted Screening for Barrett’s Esophagus and Esophageal Cancer: Post Hoc Analysis From the Randomized BEST3 Trial WK Tan, R Maroni, J Offman, SA Zamani, M di Pietro, M O’Donovan, ... Gastroenterology, 2024 | | 2024 |
| Germline variants in cancer susceptibility genes and subsequent neoplasm risks after childhood cancer: A pooled analysis of two large-scale cohorts SA Zamani, DM Karyadi, SW Hartley, JN Sampson, T Gibson, P Kraft, ... Cancer Research 84 (6_Supplement), 6155-6155, 2024 | | 2024 |
| A decade of the Oesophageal Cancer Clinical and Molecular Stratification Consortium CJ Peters, Y Ang, FD Ciccarelli, H Coles, HG Coleman, G Contino, ... Nature Medicine 30 (1), 14-16, 2024 | | 2024 |
| 1572P Impact of HER2 and PD-L1 co-expression in Claudin18. 2 positive resectable gastroesophageal cancers A Cammarota, G Devonshire, A Miremadi, A Ustaoglu, B Filippi, ... Annals of Oncology 34, S877-S878, 2023 | | 2023 |
| SO-12 CLDN18. 2 expression in resectable gastroesophageal cancers: Associated clinical and molecular signatures and impact of neoadjuvant chemotherapy on intratumor heterogeneity A Cammarota, G Devonshire, A Miremadi, L Zhuang, S Zamani, R Smith, ... Annals of Oncology 34, S166-S167, 2023 | | 2023 |
| Integrating Epidemiological and Genomic Factors to Inform Outcomes in Barrett’s Oesophagus and Oesophageal Adenocarcinoma S Zamani | | 2023 |
Rebecca FitzgeraldProfessor of Cancer Prevention, Cambridge University在 cam.ac.uk 的电子邮件经过验证
